Bioprocessing Support Services Market Report 2026

The bioprocessing support services market size has grown rapidly in recent years. It will grow from $2.1 billion in 2025 to $2.4 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to rise in monoclonal antibody production demand, expansion of contract research and manufacturing outsourcing, tightening of global regulatory frameworks for biologics, growth in biotechnology startups and funding activity, adoption of single use bioprocessing technologies.

The bioprocessing support services market size is expected to see rapid growth in the next few years. It will grow to $4.13 billion by 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing biologics pipeline complexity and diversification, rising demand for faster time to market in drug development, expansion of advanced therapy medicinal products manufacturing, growing need for global supply chain resilience in biomanufacturing, increasing emphasis on cost optimization and process efficiency in production. Major trends in the forecast period include increasing outsourcing of bioprocess development and analytical services to specialized providers, rising adoption of single use bioprocessing support solutions, growing demand for end to end regulatory compliance and documentation services, expansion of tech transfer and scale up support for complex biologics manufacturing, increasing focus on process standardization and quality assurance in biologics production.

The rising demand for biopharmaceuticals is expected to propel the growth of the bioprocessing support services market going forward. Biopharmaceuticals are medicinal products derived from biological sources, including proteins, monoclonal antibodies, vaccines, and cell and gene therapies, used for the treatment of a wide range of chronic and life-threatening diseases. The increasing demand for biopharmaceuticals is being driven by the growing prevalence of chronic conditions, continuous advancements in biotechnology, and a shift toward targeted and personalized therapeutic approaches, thereby contributing to market growth. Bioprocessing support services play a critical role in supporting this demand by providing specialized solutions such as process development, scale-up, analytical testing, and regulatory compliance support, which are essential for efficient and compliant biologics manufacturing. These services enable biopharmaceutical companies to accelerate production timelines, maintain consistent product quality, and optimize manufacturing efficiency while reducing operational complexity. For instance, according to the International Federation of Pharmaceutical Manufacturers & Associations, a U. S. trade association representing leading research-based pharmaceutical and biotechnology companies, biopharmaceutical companies in the United States spent approximately $96 billion on research and development in 2023, accounting for over 20% of total industry sales. In addition, the economic footprint of the industry remains substantial, with over $25 billion in biopharmaceutical exports generated by majority foreign-owned firms operating in the United States in 2022. Therefore, the rising demand for biopharmaceuticals is propelling the growth of the bioprocessing support services market.

Leading companies operating in the bioprocessing support services market are focusing on developing integrated bioprocessing platforms, such as chromatography resin platforms, to enhance bioprocessing efficiency and purification performance. Chromatography resin platform refers to a specialized set of engineered resins designed for use in bioprocessing and purification workflows. For example, in June 2025, Ecolab Life Sciences, a US-based provider of bioprocessing solutions, launched Purolite AP+50, an affinity chromatography resin designed to enhance antibody manufacturing efficiency. Purolite AP+50 features a 50-micron bead size, delivering the highest dynamic binding capacity within the AP resin platform, along with excellent durability for monoclonal antibody capture. Leveraging Ecolab’s patented Jetted resin bead technology, it ensures lot-to-lot consistency and reduced lead times, making it ideal for cost-effective, high-purity antibody production and streamlined operations in biopharmaceutical manufacturing.

In December 2024, Altaris, a US-based healthcare-focused investment firm, acquired the U. S. and U. K. operations of WuXi AppTec's Advanced Therapies unit, including OXGENE. Through this acquisition, Altaris intends to expand cell-therapy CDMO capabilities and establish a global footprint by combining the operations with its recently acquired Minaris Regenerative Medicine to form Minaris Advanced Therapies. OXGENE is a UK-based biotechnology company specializing in gene-therapy discovery and viral-vector manufacturing technologies, providing solutions for advanced cell and gene therapy development and manufacturing.

Major companies operating in the bioprocessing support services market are Thermo Fisher Scientific Inc., Merck KGaA, Boehringer Ingelheim International GmbH, Corning Incorporated, SGS Société Générale de Surveillance S. A., Eurofins Scientific SE, Agilent Technologies Inc., bioMérieux S. A., Sartorius AG, Getinge AB, Waters Corporation, Samsung Biologics Co. Ltd., Bio-Rad Laboratories Inc., Eppendorf AG, Repligen Corporation, Randox Laboratories Ltd, GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Rentschler Biopharma SE, Maravai LifeSciences Holdings Inc., Oxford Biomedica plc, PBS Biotech Inc., Meissner Filtration Products Inc., Bio-Synthesis Inc.

Asia-Pacific was the largest region in the bioprocessing support services market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocessing support services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the bioprocessing support services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioprocessing support services market includes revenues earned by entities through contract development and manufacturing support, process optimization consulting, quality assurance and quality control, analytical testing, equipment validation, and post-production monitoring. The market value includes the value of related services provided by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.